Form 4: Surgery Partners CSO Sells Shares for Tax Obligations

Surgery Partners' Chief Strategy Officer, Marissa Brittenham, sold 3,657 shares of common stock on March 13, 2026, to cover tax withholding obligations related to restricted stock vesting.

Summary

• Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc. (SGRY), disposed of 3,657 shares of common stock.
• The transaction occurred on March 13, 2026, at a price of $12.54 per share.
• The sale was conducted to satisfy tax withholding obligations associated with the vesting of restricted stock on March 4, 2026.
• Following this transaction, Brittenham beneficially owns 94,196 shares of Surgery Partners common stock.
• The transaction was made pursuant to a Rule 10b5-1 pre-arranged trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine administrative sale to cover tax obligations related to restricted stock vesting, which is a common occurrence for executives and does not indicate a change in company fundamentals or management's confidence.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider sales to cover tax obligations upon restricted stock vesting are common across all industries, including the healthcare services sector where Surgery Partners operates. These transactions are typically administrative and do not reflect a change in management's outlook on the company's fundamentals.

Comparison to Industry Standards

• Sales of shares to cover tax withholding obligations upon restricted stock vesting are a standard practice for executives across publicly traded companies, aligning with typical compensation structures and tax requirements.
• The use of a Rule 10b5-1 plan for such transactions is also a common corporate governance practice, demonstrating a pre-planned approach to stock sales and mitigating concerns about opportunistic trading.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but generally not indicative of a change in company value or prospects given the tax-related nature of the sale.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned sale of shares by an executive to cover tax obligations upon restricted stock vesting. Such transactions are administrative in nature and do not typically reflect a change in the company's operational performance or future outlook. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Surgery Partners, SGRY, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock, Marissa Brittenham, Chief Strategy Officer